The “Swine flu” pandemic of 2009 caused world-wide infections and deaths. Early efforts to understand its rate of spread were used to predict the probable future number of cases, but by the end of 2009 it was clear that these predictions had substantially overestimated the pandemic's eventual impact. In England, the Health Protection Agency made announcements of the number of cases of disease, which turned out to be surprisingly low for an influenza pandemic. The agency also carried out a serological survey half-way through the English epidemic. In this study, we use a mathematical model to reconcile early estimates of the rate of spread of infection, weekly data on the number of cases in the 2009 epidemic in England and the serological status of the English population at the end of the first pandemic wave. Our results reveal that if there are around 19 infections (i.e., seroconverters) for every reported case then the three data-sets are entirely consistent with each other. We go on to discuss when in the epidemic such a high ratio of seroconverters to cases of disease might have been detected, either through patterns in the case reports or through even earlier serological surveys.
References
[1]
Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, et al. (2009) Pandemic potential of a strain of inuenza A (H1N1): early findings. Science 324: 1557–61.
[2]
Health Protection Agency (2009) Weekly National Inuenza Reports. URL http://www.hpa.org.uk/web/HPAweb&HPAwebS？tandard/HPAweb_C/1244442494458.
[3]
Donaldson LJ, Rutter PD, Ellis BM, Greaves FEC, Mytton OT, et al. (2009) Mortality from pandemic A/H1N1 2009 inuenza in England: public health surveillance study. BMJ 339: b5213–b5213.
[4]
Anderson RM, May RM (1992) Infectious Diseases of Humans: Dynamics and Control (Oxford Science Publications). Oxford: Oxford University Press. 768 p. URL http://www.amazon.co.uk/Infectious-Disea？ses-Humans-Dynamics-Publications/dp/0198？54040X.
[5]
Scherer A, McLean AR (2002) Mathematical models of vaccination. Br Med Bull 62: 187–199.
[6]
Health Protection Agency (2009) Weekly Pandemic Flu Media Update. URL http://www.hpa.org.uk/NewsCentre/Nationa？lPressReleases/2009PressReleases/.
[7]
Office for National Statistics (2009) 2009 Population Estimates in England. URL http://www.statistics.gov.uk/popest.
[8]
Health Protection Agency (2009) Synopsis of the method used to estimate the number of pandemic inuenza (H1N1) 2009 cases in England in the week 21 to 27July 2009. URL http://www.hpa.org.uk/web/HPAweb&HPAwebS？tandard/HPAweb_C/1244442494458.
[9]
Health Protection Agency (2009) Method used to estimate new pandemic (H1N1) 2009 inuenza cases in England in the week 3 August to 9 August 2009. URL http://www.hpa.org.uk/web/HPAweb&HPAwebS？tandard/HPAweb_C/1244442494458.
[10]
Directgov (2009) School Term Dates. URL http://www.direct.gov.uk/en/Parents/Scho？olslearninganddevelopment/SchoolLife/DG_？4016103.
[11]
Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, et al. (2010) Incidence of 2009 pandemic inuenza A H1N1 infection in England: a cross-sectional serological study. Lancet 375: 1100–1108.
[12]
Girard MP, Tam JS, Assossou OM, Kieny MP (2010) The 2009 A (H1N1) inuenza virus pandemic: A review. Vaccine 28: 4895–4902.
[13]
Chen H (2009) Serologic Survey of Pandemic (H1N1) 2009 Virus, Guangxi Province, China. Emerg Infect Dis 41: 59–80.
[14]
Prachayangprecha S, Makkoch J, Payungporn S, Chieochansin T, Vuthitanachot C, et al. (2010) Serological analysis of human pandemic inuenza (H1N1) in Thailand. J Health Popul Nutr 28: 537–44.
[15]
Delangue J, Salez N, Ninove L, Kieffer a, Zandotti C, et al. (2011) Serological study of the 2009 pandemic due to inuenza A H1N1 in the metropolitan French population. Clin Microbiol Infect 4–10.
[16]
Mims CA, Nash A, Stephen J (2000) Mims' Pathogenesis of Infectious Disease. Academic Press. 474 p. URL http://www.amazon.co.uk/Mims-Pathogenesi？s-Infectious-Disease-Cedric/dp/012498265？4/ref=sr_1_3?s=books&ie=UTF8&qid=1309779？096&sr=1-3#.
[17]
Yang Y, Sugimoto JD, Halloran ME, Basta NE, Chao DL, et al. (2009) The transmissibility and control of pandemic inuenza A (H1N1) virus. Science 326: 729–33.
[18]
Nishiura H, Chowell G, Safan M, Castillo-Chavez C (2010) Pros and cons of estimating the reproduction number from early epidemic growth rate of inuenza A (H1N1) 2009. Theor Biol Med Model 7: 1.
[19]
Balcan D, Hu H, Goncalves B, Bajardi P, Poletto C, et al. (2009) Seasonal transmission potential and activity peaks of the new inuenza A(H1N1): a Monte Carlo likelihood analysis based on human mobility. BMC Med 7: 45.
[20]
Munayco CV, Gómez J, Arrasco J, Kochel TJ, Fiestas V, et al. (2009) Epidemiological and trans- missibility analysis of inuenza A(H1N1)v in a southern hemisphere setting: Peru. Euro Surveill 14: 1–5.
[21]
McBryde E, Bergeri I, Gemert CV, Rotty J, Headley EJ, et al. (2009) Early transmission characteristics of inuenza A(H1N1)v in Australia: Victorian state, 16 May–3 June 2009. Euro Surveill 14: 1–6.
[22]
de Silva UC, Warachit J, Waicharoen S, Chittaganpitch M (2009) A preliminary analysis of the epidemiology of inuenza A(H1N1)v virus infection in Thailand from early outbreak data, June–July 2009. Euro Surveill 14: 6–8.
[23]
Pourbohloul B, Ahued A, Davoudi B, Meza R, Meyers LA, et al. (2009) Initial human transmission dynamics of the pandemic (H1N1) 2009 virus in North America. Inuenza Other Respi Viruses 3: 215–22.
[24]
Tuite AR, Greer AL, Whelan M, Winter AL, Lee B, et al. (2010) Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 inuenza. Can Med Assoc J 182: 131–6.
[25]
Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. (2009) Emergence of a novel swineorigin inuenza A (H1N1) virus in humans. N Engl J Med 360: 2605–15.
[26]
Cauchemez S, Donnelly CA, Reed C, Ghani AC, Fraser C, et al. (2009) Household transmission of 2009 pandemic inuenza A (H1N1) virus in the United States. N Engl J Med 361: 2619–27.
[27]
Lessler J, Reich NG, Cummings DaT, Nair HP, Jordan HT, et al. (2009) Outbreak of 2009 pandemic inuenza A (H1N1) at a New York City school. N Engl J Med 361: 2628–36.
